News Snapshot:
Chinese biopharmaceutical firm Abbisko Therapeutics has floated shares in Hong Kong, while Trustar Capital has invested in Netherlands’ electric vehicles (EV) charging components major Intramco. Abbisko goes public via $225m HK IPO Abbisko Therapeutics, a Chinese clinical-stage biopharmaceutical firm, has raised about HK$1.754 billion ($225.4 million) in an initial public offering (IPO) on the main board of the Hong Kong stock exchange to advance its drug candidates. Abbisko, whose investors include Carlyle Group and Warburg Pincus, sold approximately 141 million shares at a price of HK$12.46 ($1.6) apiece on October 15. The IPO pricing was at the top end of...
